CD4 and infection: As shown in Fig. 10b, c, pMHCII-NP treated NOD.c3c4 mice mounted protective immunity against the PR8 infection, as documented by decreased viral load in lung tissue and clinical signs of active infection, despite systemic presence of cognate TR1-like CD4+ T-cells (Supplementary Fig. 7a).